semaglutide month 2 dose (Ozempic) for Type Diabetes Mellitus Semaglutide dosage chart for weight

Semaglutide is FDA-approved for type 2 diabetes (as Ozempic) and for weight loss (as Wegovy)

If the committee recommends inclusion, the FDA would still need to complete its review and rulemaking process before formally adding any of the substances to the 503A Bulks List

The only circumstances where compounding semaglutide or tirzepatide may be permissible are: True allergy to a specific inactive ingredient in the FDA-approved version, documented with allergy testing and medical records Documented medical need for a different concentration not commercially available, with clear clinical justification Specific patient population requiring dosage form modification , such as pediatric use, with proper medical justification Healthcare providers must document medical necessity with extensive clinical evidence

This process also helps reduce inflammation , which contributes to less post-treatment discomfort